Use of additive in regional blockade Transversus Abdominis Plane Block for Paediatric Laproscopic surgeries

Dexmedetomidine as an adjunct to Ropivacaine in Transversus Abdominis Plane Block for Paediatric Laproscopic surgeries

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009749

Enrollment

Registered

2017-09-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Paediatric laproscopic surgery

Interventions

Intervention1: LAD group: Dexmedetomidine 1 MCG/kg and Ropivacaine 0.2% making a total volume of 0.5 ml/kg in Transversus abdominis plane block Control Intervention1: LA group: Ropivacaine 0.2% 0.5 m

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 & ASA 2

Exclusion criteria

Exclusion criteria: 1. known containdications to peripheral nerve blockade 2. allergy to amide local anaesthetics 3. local infection at the planned injection site

Design outcomes

Primary

Measure	Time frame
To compare the time to requirement of first rescue analgesic in patients receiving TAP block.Timepoint: 0 hr,0.5 hr,1 hr,1.5 hr,2 hr,2.5 hr,3 hr,4 hr,8 hr,12 hr,18 hr,24 hr	—

Secondary

Measure	Time frame
To compare the requirement of supplemental analgesic in the first 24 hours postoperatively.Timepoint: First 24 hours postoperatively	—

Countries

India

Contacts

Public ContactDr Kashish garg

Post graduate institute of medical education and research

neerja.bhardwaj@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026